Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Conditions Affecting Sputum Viscosity
Open monograph to display formulary status.
No results found when searching the local formulary, see alternative searches below.
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Acetylcysteine
Acetylcysteine
Respiratory System, Antidotes And Chelators, Antidotes And Chelators, Other
Conditions Affecting Sputum Viscosity
Acetylcysteine
Acetylcysteine
Respiratory System, Mucolytics, Ocular Lubricants
Conditions Affecting Sputum Viscosity
Carbocisteine
Carbocisteine
Respiratory System, Mucolytics
Conditions Affecting Sputum Viscosity
Deutivacaftor
Deutivacaftor With Tezacaftor And Vanzacaftor
Respiratory System, Mucolytics
Conditions Affecting Sputum Viscosity, Cystic Fibrosis
Dornase
Dornase Alfa
Respiratory System, Mucolytics
Conditions Affecting Sputum Viscosity, Cystic Fibrosis
Erdosteine
Erdosteine
Respiratory System, Mucolytics
Conditions Affecting Sputum Viscosity
Ivacaftor
Ivacaftor
Respiratory System, Mucolytics
Conditions Affecting Sputum Viscosity, Cystic Fibrosis
Ivacaftor
Ivacaftor With Tezacaftor And Elexacaftor
Respiratory System, Mucolytics
Conditions Affecting Sputum Viscosity, Cystic Fibrosis
Lumacaftor
Lumacaftor With Ivacaftor
Respiratory System, Mucolytics
Conditions Affecting Sputum Viscosity, Cystic Fibrosis
Mannitol
Mannitol
Respiratory System, Diuretics, Osmotic Diuretics
Conditions Affecting Sputum Viscosity, Cystic Fibrosis
Mannitol
Mannitol
Respiratory System, Mucolytics
Conditions Affecting Sputum Viscosity, Cystic Fibrosis
Tezacaftor
Tezacaftor With Ivacaftor
Respiratory System, Mucolytics
Conditions Affecting Sputum Viscosity, Cystic Fibrosis
No exact matches found - Possible matches - use with care.
Status
Description
Section
RED
Cimetidine
Gastro-intestinal system, H2-receptor antagonists, 01.03.01